August 13, 2025

The Prognostic Significance of the Serum Inflammatory Marker Ratios, Neutrophil-Lymphocyte, Platelet-Lymphocyte and Monocyte-Lymphocyte in Male Breast Cancer.

View Full Paper

Ask AI

Bookmark

Authors

DMDylan Peter McClurgCancer Research UK MWMichael K. WongRoswell Park Comprehensive Cancer Center KTKirsty Luo-Yng TayUniversity of Aberdeen

Discussion

Member takes

Implication

Retrospective analysis assessed neutrophil-lymphocyte and platelet-lymphocyte ratios in male breast cancer, indicating their role in overall survival.

Key Points

Elevated neutrophil-lymphocyte ratio (≥3.23) linked to decreased overall survival in male breast cancer patients.
Platelet-lymphocyte ratio (≥129.53) also associated with poorer outcomes in the same patient group.
Data showed severely obese patients had higher platelet-lymphocyte and monocyte-lymphocyte ratios pre-operatively.
Study suggests that refined cut-off values for these biomarkers are critical for effective management of male breast cancer.

Cite This Study

McClurg et al. (2025) studied this question.

synapsesocial.com/papers/689e03efd61984b91e13d62e https://doi.org/10.1080/07357907.2025.2523908

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis assessed neutrophil-lymphocyte and platelet-lymphocyte ratios in male breast cancer, indicating their role in overall survival.

The Prognostic Significance of the Serum Inflammatory Marker Ratios, Neutrophil-Lymphocyte, Platelet-Lymphocyte and Monocyte-Lymphocyte in Male Breast Cancer.

Discussion

Member takes

Implication

Key Points

Cite This Study

The Prognostic Significance of the Serum Inflammatory Marker Ratios, Neutrophil-Lymphocyte, Platelet-Lymphocyte and Monocyte-Lymphocyte in Male Breast Cancer.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider